<code id='B825B82B3E'></code><style id='B825B82B3E'></style>
    • <acronym id='B825B82B3E'></acronym>
      <center id='B825B82B3E'><center id='B825B82B3E'><tfoot id='B825B82B3E'></tfoot></center><abbr id='B825B82B3E'><dir id='B825B82B3E'><tfoot id='B825B82B3E'></tfoot><noframes id='B825B82B3E'>

    • <optgroup id='B825B82B3E'><strike id='B825B82B3E'><sup id='B825B82B3E'></sup></strike><code id='B825B82B3E'></code></optgroup>
        1. <b id='B825B82B3E'><label id='B825B82B3E'><select id='B825B82B3E'><dt id='B825B82B3E'><span id='B825B82B3E'></span></dt></select></label></b><u id='B825B82B3E'></u>
          <i id='B825B82B3E'><strike id='B825B82B3E'><tt id='B825B82B3E'><pre id='B825B82B3E'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:112
          Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT
          Adobe

          Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

          The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

          advertisement

          The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In
          Previous article: Study fuels hope CAR
          Next article: Alkermes shareholders re

          explore

          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more
          Using force crossed my mind when examining a defiant young patient
          Using force crossed my mind when examining a defiant young patient

          Inthis1895photo,nursesanddoctorsinoculateachildwithdiphtheriaantitoxinatthePasteurInstituteinNewYork

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Roche acquires Telavant from Roivant, adding experimental IBD treatment

          SebastienBozon/AFPviaGettyImagesRochesaidMondayitwasbuyingTelavantHoldingsfor$7.1billionupfront,pick